2018 Association for Molecular Pathology (AMP)
Visit HTG at booth 1008 at the 2018 Annual AMP meeting to learn how our collaborators are innovating next-generation pathology with the NGS-based HTG EdgeSeq system and assays.
News & Events
NATURE SHORTCAST: Utilizing GEP to Integrate Biomarker Data and Illuminate Complex Biology
Given the inherently complex and dynamic relationship between cancer biology and the immune system, there is great benefit to utilizing high-plex transcriptomic profiling assays to survey broad aspects of biology.
- Category:
- Past Events
HTG Molecular Announces Extension to Precision Diagnostic Partnership (PDP) Program Three for Companion Diagnostic Submission
TUCSON, Ariz., Sept. 27, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into an amendment to the third statement of work (“SOW Three”) under its Master Assay Development, Commercialization and Manufacturing Agreement with QIAGEN Manchester Limited (“QIAGEN”).
- Category:
- Press Releases
HTG Molecular Announces Extension to Precision Diagnostic Partnership (PDP) Program Three for Companion Diagnostic Submission
TUCSON, Ariz. , Sept. 27, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into an amendment to the third statement of work (“SOW Three”)…
- Category:
- Press Releases
HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
TUCSON, Ariz. , Sept. 26, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cantor…
- Category:
- Press Releases
Nature Webcast: Utilizing GEP to Integrate Biomarker Data and Illuminate Complex Biology
Given the inherently complex and dynamic relationship between cancer biology and the immune system, there is great benefit to utilizing high-plex transcriptomic profiling assays to survey broad aspects of biology.
- Category:
- Past Events
HTG Molecular to Present a Corporate Overview at the H.C. Wainwright 20th Annual Global Investment Conference
TUCSON, Ariz. , Aug. 30, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the H.C. …
- Category:
- Press Releases
HTG Introduces the HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay, a Comprehensive Panel for miRNA Expression Analysis for use in Translational Medicine and Preclinical Studies
TUCSON, Ariz. , Aug. 29, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the pre-launch introduction of the new HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay …
- Category:
- Press Releases
HTG Molecular Announces 2nd Amendment to Second Statement of Work with QIAGEN Manchester Limited
TUCSON, Ariz. , Aug. 20, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into a second amendment to the second statement of work (“SOW Two”) …
- Category:
- Press Releases
HTG Molecular Appoints Michelle R. Griffin to its Board of Directors
TUCSON, Ariz. , Aug. 16, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the appointment of Ms. Michelle Griffin to its Board of Directors. “We are pleased to …
- Category:
- Press Releases
HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel
TUCSON, Ariz. , Aug. 15, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced it launched its HTG EdgeSeq Precision Immuno-Oncology Panel and has delivered its first …
- Category:
- Press Releases
HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited
TUCSON, Ariz. , Aug. 09, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into an amendment to the second statement of work (“SOW Two”) under …
- Category:
- Press Releases
Page last updated March 20, 2023